Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01379209
Recruitment Status : Unknown
Verified October 2015 by Regimmune Inc..
Recruitment status was:  Active, not recruiting
First Posted : June 23, 2011
Last Update Posted : October 27, 2015
Pacific-Link Regulatory Consulting LLC
Information provided by (Responsible Party):
Regimmune Inc.

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Actual Primary Completion Date : June 2015
  Estimated Study Completion Date : December 2015